BCR and primary central nervous system lymphoma: [17, 37, 38] XPO1 inhibition forces nuclear localization of tumor suppressors and also interferes with additional signaling pathways, including NF-κB and BCR, which are crucial for survival of malignant B cells in general and for PCNSL cells in particular.